GEN Exclusives

More »

GEN News Highlights

More »
Jul 9, 2009

AstraZeneca Extends Agreement to Use Linguamatics’ Text-Mining Technology

  • AstraZeneca extended its license to Linguamatics’ I2E interactive information extraction system with a further multiyear deal. The company has been a customer of Linguamatics since 2003. I2E uses natural language processing-based text-mining technology to provide insights from literature sources in real-time. The platform supports decision making at many points in the drug discovery process including target selection, biomarker discovery, and safety/toxicology.


GEN Jobs powered by connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
More »

Be sure to take the GEN Poll

Disclosing Clinical Trial Data

Do you believe that conducting performance audits for new drugs will incentivize pharma firms to become more transparent?

More »